National Research Corporation (NRCIA) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its holdings in National Research Corporation (NASDAQ:NRCIA) by 1.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 96,518 shares of the business services provider’s stock after selling 1,906 shares during the period. Bank of New York Mellon Corp owned about 0.40% of National Research Corporation worth $2,596,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in NRCIA. Algert Global LLC acquired a new position in shares of National Research Corporation in the second quarter valued at approximately $384,000. Strs Ohio grew its position in shares of National Research Corporation by 210.3% in the second quarter. Strs Ohio now owns 12,100 shares of the business services provider’s stock valued at $325,000 after purchasing an additional 8,200 shares during the last quarter. Schwab Charles Investment Management Inc. grew its position in shares of National Research Corporation by 0.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 30,453 shares of the business services provider’s stock valued at $820,000 after purchasing an additional 190 shares during the last quarter. Finally, Rice Hall James & Associates LLC grew its position in shares of National Research Corporation by 1.0% in the second quarter. Rice Hall James & Associates LLC now owns 15,035 shares of the business services provider’s stock valued at $404,000 after purchasing an additional 155 shares during the last quarter. Hedge funds and other institutional investors own 28.80% of the company’s stock.

Separately, Zacks Investment Research downgraded National Research Corporation from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 5th.

Shares of National Research Corporation (NASDAQ:NRCIA) opened at 36.90 on Friday. The firm has a 50 day moving average price of $35.35 and a 200-day moving average price of $28.26. The firm has a market cap of $896.63 million, a P/E ratio of 40.64 and a beta of 1.72. National Research Corporation has a one year low of $14.35 and a one year high of $41.99.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a $0.10 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.40 annualized dividend and a yield of 1.08%. National Research Corporation’s dividend payout ratio (DPR) is presently 76.92%.

TRADEMARK VIOLATION WARNING: “National Research Corporation (NRCIA) Shares Sold by Bank of New York Mellon Corp” was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.com-unik.info/2017/10/13/national-research-corporation-nrcia-shares-sold-by-bank-of-new-york-mellon-corp.html.

National Research Corporation Profile

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Want to see what other hedge funds are holding NRCIA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRCIA).

Institutional Ownership by Quarter for National Research Corporation (NASDAQ:NRCIA)

What are top analysts saying about National Research Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for National Research Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit